Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel J Pyne

Showing results (1-10 of 105) with videos related to

Pageof 11
Sort By:
Frontiers in Pharmacology|June 21, 2011
Selectivity and specificity of sphingosine 1-phosphate receptor ligands: "off-targets" or complex pharmacology?Nigel J Pyne, Susan Pyne
Oncotarget|April 30, 2017
Sphingosine kinase 2 and multiple myelomaNigel J Pyne, Susan Pyne
Biochimica Et Biophysica Acta|June 19, 2002
Sphingosine 1-phosphate signalling and termination at lipid phosphate receptorsSusan Pyne, Nigel J Pyne
Molecules (Basel, Switzerland)|March 1, 2017
Sphingosine 1-Phosphate Receptor 1 Signaling in Mammalian CellsNigel J Pyne, Susan Pyne
Biochimica Et Biophysica Acta|June 19, 2008
Sphingosine 1-phosphate, lysophosphatidic acid and growth factor signaling and terminationNigel J Pyne, Susan Pyne
Cancer Cell|January 19, 2013
Sphingosine 1-phosphate is a missing link between chronic inflammation and colon cancerNigel J Pyne, Susan Pyne
Nature Reviews. Cancer|June 18, 2010
Sphingosine 1-phosphate and cancerNigel J Pyne, Susan Pyne
Trends in Pharmacological Sciences|May 27, 2011
Receptor tyrosine kinase-G-protein-coupled receptor signalling platforms: out of the shadow?Nigel J Pyne, Susan Pyne
Trends in Molecular Medicine|April 26, 2011
Translational aspects of sphingosine 1-phosphate biologySusan Pyne, Nigel J Pyne
Handbook of Experimental Pharmacology|April 9, 2013
New perspectives on the role of sphingosine 1-phosphate in cancerSusan Pyne, Nigel J Pyne
Pageof 11

Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
Frontiers in Pharmacology|June 21, 2011
Selectivity and specificity of sphingosine 1-phosphate receptor ligands: "off-targets" or complex pharmacology?Nigel J Pyne, Susan Pyne
Oncotarget|April 30, 2017
Sphingosine kinase 2 and multiple myelomaNigel J Pyne, Susan Pyne
Biochimica Et Biophysica Acta|June 19, 2002
Sphingosine 1-phosphate signalling and termination at lipid phosphate receptorsSusan Pyne, Nigel J Pyne
Molecules (Basel, Switzerland)|March 1, 2017
Sphingosine 1-Phosphate Receptor 1 Signaling in Mammalian CellsNigel J Pyne, Susan Pyne
Biochimica Et Biophysica Acta|June 19, 2008
Sphingosine 1-phosphate, lysophosphatidic acid and growth factor signaling and terminationNigel J Pyne, Susan Pyne
Cancer Cell|January 19, 2013
Sphingosine 1-phosphate is a missing link between chronic inflammation and colon cancerNigel J Pyne, Susan Pyne
Nature Reviews. Cancer|June 18, 2010
Sphingosine 1-phosphate and cancerNigel J Pyne, Susan Pyne
Trends in Pharmacological Sciences|May 27, 2011
Receptor tyrosine kinase-G-protein-coupled receptor signalling platforms: out of the shadow?Nigel J Pyne, Susan Pyne
Trends in Molecular Medicine|April 26, 2011
Translational aspects of sphingosine 1-phosphate biologySusan Pyne, Nigel J Pyne
Handbook of Experimental Pharmacology|April 9, 2013
New perspectives on the role of sphingosine 1-phosphate in cancerSusan Pyne, Nigel J Pyne
Pageof 11